Evidence map›Paper›PMID 35329919›Full record

ReviewJournal of clinical medicine2022

Prevalence of Opioid Use Disorder among Patients with Cancer-Related Pain: A Systematic Review.

Céline Preux, Marion Bertin, Andréa Tarot, Nicolas Authier, Nathalie Pinol, David Brugnon, Bruno Pereira, Virginie Guastella

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Cancer pain.Nature reviews. Disease primers · 2026
    Review
  3. Comment on: identifying opioid misuse in cancer pain: validation of the prescription opioid misuse index in a multicenter study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  4. Article
  5. Review
  6. Identifying opioid misuse in cancer pain: validation of the prescription opioid misuse index in a multicenter study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Observational
  7. Frequency and predictors of risk of non-medical opioid use among patients with cancer in a specialized outpatient palliative care clinic.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  8. Association between pain medication misuse, psychological distress, and opioid use disorder among adults with lifetime cancer diagnosis in the United States.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  9. Review
  10. Article
  11. How Racialized Approaches to Opioid Use Disorder and Opioid Misuse Management Hamper Pharmacoequity for Cancer Pain.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  12. Article
  13. The contribution of nonmedical opioid use to healthcare encounters for opioid overdose and use disorders among long-term users with metastatic cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  14. Article
  15. Buprenorphine Use for Analgesia in Palliative Care.Pharmacy (Basel, Switzerland) · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Ethical considerations in the relief of cancer pain.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Céline PreuxPalliative Care Center, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
Marion BertinPalliative Care Center, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
Andréa TarotPalliative Care Center, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
Nicolas AuthierNeuro-Dol, Service Pharmacologie Médicale, Centres d'Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm, CHU Clermont-Ferrand, Université de Clermont Auvergne, F-63001 Clermont-Ferrand, France.
Nathalie PinolCentre de Documentation et Recherche de la Faculté de Médecine, CHU Clermont-Ferrand, Université de Clermont Auvergne, F-63000 Clermont-Ferrand, France.
David BrugnonPalliative Care Center, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
Bruno PereiraUnité de Biostatistiques, Direction de la Recherche Clinique et de l'Innovation, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.ORCID 0000-0003-3778-7161
Virginie GuastellaPalliative Care Center, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.ORCID 0000-0002-5712-8887
Centre Hospitalier Universitaire de Clermont-Ferrand · FRInserm · FRUniversité Clermont Auvergne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe opioid use disorder is an international public health problem. Over the past 20 years it has been the subject of numerous publications concerning patients treated for chronic pain other than cancer-related. Patients with cancer-related pain are also at risk of opioid use disorder. The primary objective of this literature review was to determine the prevalence of opioid use disorder in patients with cancer-related chronic pain. Its secondary objective was to identify the characteristics of these opioid users.

methodsThis is a literature review of studies published over the last twenty years, from 1 January 2000 to 31 December 2020 identified by searching the three main medical databases: Pubmed, Cochrane, and Embase. A meta-analysis took account of between and within-study variability with the use of random-effects models estimated by the DerSimonian and Laird method.

resultsThe prevalence of opioid use disorder was 8% (1-20%) and of the risk of use disorder was 23.5% (19.5-27.8%) with

conclusionsFurther studies are now needed on the prevalence of opioid use disorder in patients treated for cancer-related chronic pain. A screening scale adapted to this patient population is urgently needed.

Indexed as

cancerchronic painmeta-analysisopioid use disorderprevalencesystematic review

Identifiers

PMID35329919
PMCPMC8954099
OpenAlexW4220876984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.